As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...
CeRAI at IIT-Madras partners with Roche for AI research in diagnostics, focusing on responsible and ethical AI solutions.
Quest Diagnostics Inc. hit a new 52-week high, surpassing its previous peak of $168.17, which the company achieved on February 11th.
According to Statifacts, the global Immunoassay market size is calculated at USD 32,820 million in 2024 and is expected to ...
UBS analyst Matthew Weston upgraded Roche Holding (OTC:RHHBY) stock from Neutral to Buy, adjusting the price target to CHF 338.00, up from the previous CHF 300.00. The upgrade comes as the stock ...
We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...
Biogen Inc. (NASDAQ:BIIB), currently valued at $19.15 billion by market capitalization, reported its earnings for the fourth ...
Detailed price information for Butterfly Network Inc (BFLY-N) from The Globe and Mail including charting and trades.
We recently published a list of 10 Best Annual Dividend Stocks To Buy Now. In this article, we are going to take a look at where Roche Holding AG (OTC:RHHBY) stands against other best annual dividend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results